Results 181 to 190 of about 97,449 (305)
Deceptive clinical course of mucinous ovarian carcinoma mimicking pelvic abscess in a postmenopausal woman: An exceptional case report. [PDF]
Jarathi A +10 more
europepmc +1 more source
This study develops a nano‐enzyme patch (ezPatch) targeting bone interfaces. Utilizing ligand‐to‐metal charge transfer (LMCT) catalysis and bone‐targeting ligands on copper nanosheets, ezPatch simultaneously scavenges reactive oxygen species (ROS) and generates oxygen in situ at bone‐losing sites.
Yi Chen +12 more
wiley +1 more source
Ovarian Tuberculosis Mimicking Ovarian Malignancy: A Diagnostic Challenge in an Endemic Setting. [PDF]
Galaviz Valdez ME +2 more
europepmc +1 more source
ABSTRACT Fluorouracil‐platinum(IV) prodrugs represent a novel class of multimechanistic chemotherapeutics with enhanced anticancer potential. The prodrugs PtIVP‐5FUMeOBut and PtIV56‐5FUMeOBut were actualized by derivatising the clinical drug 5‐fluorouracil (5FU) and coordinating it to platinum(IV) complexes, leveraging the established cytotoxicity of ...
Maria George Elias +9 more
wiley +1 more source
Case Report of a Large Ovarian Cyst in a Multiparous Woman: A Challenging Surgical Management. [PDF]
Kasar IT +9 more
europepmc +1 more source
The Fruits of Conservatism in the Treatment of Ovarian Pathology [PDF]
Christian, Howard J.
core +1 more source
Boron Neutron Capture Therapy at a Crossroads: Translational Gap and Emerging Delivery Agents
This review surveys recent advances in boron delivery agents for BNCT, emphasizing the shift from classical small molecules to multifunctional nanocarriers and theranostic systems. By integrating targeting, imaging, and therapy, next‐generation boron compounds aim to bridge the gap between (bio)chemical innovation and clinical translation.
Christoph Selg, Evamarie Hey‐Hawkins
wiley +1 more source
Risk Factors and Preoperative Prediction Model for Endometrial Lesions in Postmenopausal Patients with Benign Ovarian Tumors: A Retrospective Single-Center Study. [PDF]
Wang T, Tian L, Yan Y, Zhao S, Wang Y.
europepmc +1 more source
ABSTRACT Lipid nanoparticles (LNPs) represent the most clinically advanced platform for RNA delivery and have enabled major breakthroughs in vaccines and gene therapies. However, their broader application is still limited by inefficient extrahepatic delivery, immunogenicity, and insufficient control over tissue‐ and cell‐specific targeting. This review
Yu Han +5 more
wiley +1 more source

